Linked Life Data

20123491

Source:http://linkedlifedata.com/resource/pubmed/id/20123491

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2010-2-3
pubmed:abstractText
The management of cancer in the elderly patients is becoming a major problem of public health. The population is becoming older, the risk of cancer is increasing with age and therapeutic tools are improving. The numerous pharmacological changes of age might influence the pharmacokinetic and pharmacodynamic variables of many drugs, in particular the agents of chemotherapy. The development of news drugs, with less toxicity, administrated weekly or orally, and of supportive care (hematological growth factors, nutritional support) allows proposing specific treatment to elderly patients with cancer. However, evidence-based medicine data are lacking to define optimal schedules in this population due to low inclusion rates in clinical trials. This paper explores the specificities of chemotherapy in elderly patients with cancer.
pubmed:commentsCorrections
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1166-7087
pubmed:author
pubmed:copyrightInfo
(c) 2009 Elsevier Masson SAS. All rights reserved.
pubmed:issnType
Print
pubmed:volume
19 Suppl 3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S100-5
pubmed:dateRevised
2010-8-2
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
[Specificities of chemotherapy in elderly cancer patients].
pubmed:affiliation
Service d'Oncologie Médicale, Unité d'Onco-gériatrie, CHU Henri Mondor, Université Paris 12, Paris, France.
pubmed:publicationType
Journal Article, English Abstract, Review